Chondroitin sulfate-binding peptides block chondroitin 6-sulfate inhibition of cortical neurite growth

Neuroscience Letters

Volumn 478, Issue 2, 2010, Pages 82-87

  Butterfield, Karen Chao ^a   Conovaloff, Aaron ^b   Caplan, Michael ^a   Panitch, Alyssa ^b  

^a Arizona State University   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Chondroitin sulfate; Chondroitin sulfate binding peptide; Cortical neurons; Spinal cord injury

Indexed keywords

CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM CORTEX; CONTROLLED STUDY; EMBRYO; NERVE CELL INHIBITION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CHONDROITIN SULFATES; EMBRYO, MAMMALIAN; NEURITES; PEPTIDES; RATS;

EID: 77953611846     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.070     Document Type: Article

References (30)

1. Asher R.A., Morgenstern D.A., Shearer M.C., Adcock K.H., Pesheva P., Fawcett J.W. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J. Neurosci. 2002, 22:2225-2236.
2. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
3. Brewer G.J. Serum-free B27/Neurobasal medium supports differentiated growth of neurons from the striatum, substantia-nigra, septum, cerebral-cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 1995, 42:674-683.
4. Butterfield K.C., Caplan M., Panitch A. Identification and sequence composition characterization of chondroitin sulfate-binding peptides through peptide array screening. Biochemistry 2010, 49:1549-1555.
5. Carulli D., Laabs T., Geller H.M., Fawcett J.W. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 2005, 15:116-120.
6. Clement A.M., Nadanaka S., Masayama K., Mandl C., Sugahara K., Faissner A. The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J. Biol. Chem. 1998, 273:28444-28453.
7. Clement A.M., Sugahara K., Faissner A. Chondroitin sulfate E promotes neurite outgrowth of rat embryonic day 18 hippocampal neurons. Neurosci. Lett. 1999, 269:125-128.
8. D. Eng, M. Caplan, M. Preul, A. Panitch, Hyaluronan scaffolds: a balance between backbone functionalization and bioactivity, Acta. Biomater. (2010) . doi:10.1016/j.actbio.2009.12.049.
9. Faissner A., Clement A., Lochter A., Streit A., Mandl C., Schachner M. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J. Cell. Biol. 1994, 126:783-799.
10. Fernaud-Espinosa I., Nieto-Sampedro M., Bovolenta P. Differential effects of glycosaminoglycans on neurite outgrowth from hippocampal and thalamic neurones. J. Cell. Sci. 1994, 107(Pt 6):1437-1448.
11. Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 1997, 148:587-603.
12. Gama C.I., Tully S.E., Sotogaku N., Clark P.M., Rawat M., Vaidehi N., Goddard W.A., Nishi A., Hsieh-Wilson L.C. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat. Chem. Biol. 2006, 2:467-473.
13. Garcia-Alias G., Barkhuysen S., Buckle M., Fawcett J.W. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 2009, 12:1145-1151.
14. Garwood J., Schnadelbach O., Clement A., Schutte K., Bach A., Faissner A. DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage. J. Neurosci. 1999, 19:3888-3899.
15. Gilbert R.J., McKeon R.J., Darr A., Calabro A., Hascall V.C., Bellamkonda R.V. CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol. Cell. Neurosci. 2005, 29:545-558.
16. Hains B.C., Black J.A., Waxman S.G. Primary cortical motor neurons undergo apoptosis after axotomizing spinal cord injury. J. Comp. Neurol. 2003, 462:328-341.
17. Hynds D.L., Snow D.M. Neurite outgrowth inhibition by chondroitin sulfate proteoglycan: stalling/stopping exceeds turning in human neuroblastoma growth cones. Exp. Neurol. 1999, 160:244-255.
18. Jones L.L., Yamaguchi Y., Stallcup W.B., Tuszynski M.H. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 2002, 22:2792-2803.
19. Lee H., McKeon R.J., Bellamkonda R.V. Regenerative Medicine Special Feature: Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 2009.
20. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 1995, 136:32-43.
21. Nadanaka S., Clement A., Masayama K., Faissner A., Sugahara K. Characteristic hexasaccharide sequences in octasaccharides derived from shark cartilage chondroitin sulfate D with a neurite outgrowth promoting activity. J. Biol. Chem. 1998, 273:3296-3307.
22. Properzi F., Carulli D., Asher R.A., Muir E., Camargo L.M., van Kuppevelt T.H., ten Dam G.B., Furukawa Y., Mikami T., Sugahara K., Toida T., Geller H.M., Fawcett J.W. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur. J. Neurosci. 2005, 21:378-390.
23. Shipp E.L., Hsieh-Wilson L.C. Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays. Chem. Biol. 2007, 14:195-208.
24. Smith-Thomas L.C., Fok-Seang J., Stevens J., Du J.S., Muir E., Faissner A., Geller H.M., Rogers J.H., Fawcett J.W. An inhibitor of neurite outgrowth produced by astrocytes. J. Cell. Sci. 1994, 107(Pt 6):1687-1695.
25. Snow D.M., Brown E.M., Letourneau P.C. Growth cone behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or fibronectin. Int. J. Dev. Neurosci. 1996, 14:331-349.
26. Snow D.M., Mullins N., Hynds D.L. Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. Microsc. Res. Technol. 2001, 54:273-286.
27. Tully S.E., Mabon R., Gama C.I., Tsai S.M., Liu X., Hsieh-Wilson L.C. A chondroitin sulfate small molecule that stimulates neuronal growth. J. Am. Chem. Soc. 2004, 126:7736-7737.
28. Tully S.E., Rawat M., Hsieh-Wilson L.C. Discovery of a TNF-alpha antagonist using chondroitin sulfate microarrays. J. Am. Chem. Soc. 2006, 128:7740-7741.
29. Wang H., Katagiri Y., McCann T.E., Unsworth E., Goldsmith P., Yu Z.X., Tan F., Santiago L., Mills E.M., Wang Y., Symes A.J., Geller H.M. Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J. Cell. Sci. 2008, 121:3083-3091.
30. Zhang Y., Tohyama K., Winterbottom J.K., Haque N.S., Schachner M., Lieberman A.R., Anderson P.N. Correlation between putative inhibitory molecules at the dorsal root entry zone and failure of dorsal root axonal regeneration. Mol. Cell. Neurosci. 2001, 17:444-459.